Search For "her2"
Hetero Healthcare and Enzene Launch Perzea: Affordable Pertuzumab Biosimil
Updated : 5 months, 1 week ago IST
Hyderabad (Telangana) [India], September 25: In a landmark initiative to expand affordable breast cancer treatment in India, Hetero Healthcare Limited has announced the launch of Perzea, its most cost-effective biosimilar of Pertuzumab. Developed through a semi-exclusive collaboration with E
Read More
Complex, rare case of breast cancer during pregnancy; both mother and chil
Updated : 6 months, 2 weeks ago IST
A 35-year-old woman, five months pregnant, was diagnosed with triple-positive breast cancer in July 2024, highlighting the complexities of treating cancer during pregnancy.
Read More
Goa to provide Pertuzumab-Trastuzumab drug combo free to Her2 breast cance
Updated : 2 years, 1 month ago IST
As the world marks #WorldCancerDay, the state of Goa on Sunday announced significant strides in cancer care, promising free access to the Pertuzumab-Trastuzumab drug combination for those battling Her2 breast cancer.
Read More
Adding ribociclib to hormone therapy improves outcomes for patients with e
Updated : 2 years, 9 months ago IST
A study found that patients with early hormone-receptor (HR) positive/HER2 negative breast cancer had a significant advantage in invasive disease-free survival when ribociclib, a targeted therapy medicine, was added to hormone treatment.
Read More
Study finds how adding ribociclib to hormone therapy improves results in e
Updated : 2 years, 9 months ago IST
A study discovered that when ribociclib, a targeted therapy medicine, is added to hormone treatment, patients with early hormone-receptor (HR) positive/HER2 negative breast cancer had a substantial invasive disease-free survival advantage.
Read More
AstraZeneca gets approval to import breast cancer treatment drug in India
Updated : 2 years, 10 months ago IST
AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, on Wednesday announced that it has received approval from the Drug Controller General of India (DCGI) for the cancer drug Trastuzumab Deruxtecan for the treatment of metastatic breast cancer.
Read More
Switch of breast tumors to HER2-low might provide greater therapeutic opti
Updated : 4 years, 10 months ago IST
Lugano [Switzerland], May 9 (ANI): The finding that breast tumours can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently in clinical trials for HER2-low t
Read More
Scientists unveil drug-duo to fight off cancer
Updated : 6 years, 1 month ago IST
Texas [USA], Jan 24 (ANI): Scientists have figured out a combination of two drugs that show promise in halting the proliferation of cancer cells that harbour a specific gene mutation.
Read More
A new target for 'triple-negative' breast cancer
Updated : 8 years, 3 months ago IST
Washington D.C. [USA], Nov 21 (ANI): A team of scientists has found a new target for triple-negative breast cancer.
Read More